Imunon Inc (IMNN NASDAQ) stock market data APIs
$1.2428
0.05(4%)
as of October 5, 2026
Try our APIs with
free plan!
Imunon Inc Financial Data Overview
Price chart is built with
Anychart
Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma. It is also developing IMNN-101, a COVID-19 booster vaccine that has completed a Phase 1 clinical trial. In addition, the company develops non-viral DNA technology across modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; and PlaCCine for the coding of viral antigens that can elicit a strong immunological response. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was incorporated in 1982 and is headquartered in Lawrenceville, New Jersey.
Prev. Close
1.2428
Open
1.2975
High
1.3105
Low
1.2128
52 wk Range
1.22-5.4
Market Cap
6 958 K
Shares Outstanding
5 611 K
Revenue
125 K
EPS
-0.54
Beta
2.005
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Imunon Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Imunon Inc data using free add-ons & libraries
Get Imunon Inc Fundamental Data
Imunon Inc Fundamental data includes:
- Net Revenue: 125 K
- EBITDA: -14 545 411
- Earnings Per Share: -3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-11
- EPS/Forecast: -0.94
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Imunon Inc News
New
Imunon (IMNN) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, Aug. 11, 2026 at 11 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Stacy R. LindborgChief Medical Officer - Douglas V. FallerInterim...
Imunon outlines OVATION 3 enrollment pace of 0.5 patients per site per month while planning early 2027 OVATION 2 data presentation
Earnings Call Insights: Imunon, Inc. (IMNN) Q2 2026 MANAGEMENT VIEW * “The second quarter marked another period of focused execution and key validation of both IMNN-001, our lead asset, and our ...
IMUNON Advances OVATION 3 Trial Of IMNN-001; Enrollment Expected To Complete In 1H29
(RTTNews) - IMUNON, Inc. (IMNN), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, reported its second-quarter 2026 financial results and provided a business update, with...
Here are the major earnings before the open Tuesday
Major earnings expected before the bell on Tuesday include: * Pfizer (PFE [https://seekingalpha.com/symbol/PFE]) * Energy Transfer LP (ET [https://seekingalpha.com/symbol/ET]) * Merck & Co. (MR...
Get Imunon Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.